Blood Draw

Devices, Funding, Pharmacy June 29, 2021

Babson Diagnostics $31 Million Series B to Drive
Retailization of Customer-First, Highly Accessible
Diagnostic Blood Testing

Funding Marks Latest Milestone on Path to Commercialization Babson Diagnostics, a transformative medical technology company improving customer access to diagnostic blood testing, today announced the closing of $31 million in an oversubscribed Series B funding…

Devices, Technology October 17, 2019

Drawbridge Health Receives FDA 510(k) Clearance for OneDraw™ A1C Test System

Drawbridge Health today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the OneDraw™ A1C Test System, comprised of the OneDraw Blood Collection Device and the OneDraw A1C Test. The OneDraw A1C…